In the present study, we developed a new small 99mTc-labeled PD-L1 affibody molecular probe (99mTc-PDA) for SPECT imaging and evaluated its binding properties in vitro and in vivo, biodistribution, and targeting properties in PD-L1 receptor-positive tumor models. This evidence concerns the gene CD274 and neoplasm.